MR1 and cancer: Both in the context of bacterial infections (73, 88), cancer and steady-state (44, 90) there is evidence for the existence of additional MR1 ligands, including some that do not appear to be pyrimidines or ribityllumazines (73, 88), although the chemical identities of these remain to be defined.